ArticleCancer research2018

HLA Class I and II Diversity Contributes to the Etiologic Heterogeneity of Non-Hodgkin Lymphoma Subtypes.

Sophia S Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.